BlueCrest Capital Management’s Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 CPUH.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding CPUH.WS
LP
SRCM
PIF
JRCM
PAMP
AC
ETH
SCM
TP
BlueCrest Capital Management's CPUH.WS Position: Q1 2023 in Review
BlueCrest Capital Management sold out of Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (CPUH.WS) in Q1 2023, closing a stake of 1,716,700 shares — an estimated $1.93K sold.
BlueCrest Capital Management first reported a position in CPUH.WS in Q3 2021 and held it in 2 quarters. The position peaked at $113K in Q3 2021. 61 funds tracked by Wall St. Rank hold CPUH.WS as of Q1 2023.
- BlueCrest Capital Management reported no remaining Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q1 2023 after selling out during the quarter.
- BlueCrest Capital Management sold 1,716,700 Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q1 2023, an estimated $1.93K.
- BlueCrest Capital Management first reported a position in Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q3 2021 and held it in 2 quarters.
- BlueCrest Capital Management's Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $113K in Q3 2021.
- 61 funds tracked by Wall St. Rank held Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q1 2023.
Based on BlueCrest Capital Management's 13F filing for Q1 2023, filed 15 May 2023.